Articles

Entasis Therapeutics Holdings, Inc. Articles

November 17, 2020GlobeNewswirePress Release

Entasis Therapeutics to Participate in A.G.P.'s Virtual Healthcare Symposium

WALTHAM, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), ... See more »
November 6, 2020Boston CitybizlistNews

Entasis Therapeutics Provides a Business Update

October 14, 2020BenzingaNews

Entasis Therapeutics Highlights Multiple Data Presentations at Virtual ID Week

WALTHAM, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX), a... See more »
September 25, 2020Zolmax NewsNews

Entasis Therapeutics Holdings Inc (NASDAQ:ETTX) Position Boosted by Bridgeway Capital Management Inc.

Bridgeway Capital Management Inc. boosted its position in Entasis Therapeutics Holdings Inc (NASDAQ:E... See more »
September 13, 2020Zolmax NewsNews

Entasis Therapeutics Holdings Inc to Post FY2020 Earnings of ($3.20) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:ETTX)

Entasis Therapeutics Holdings Inc (NASDAQ:ETTX) - Research analysts at Cantor Fitzgerald issued their... See more »
September 10, 2020GlobalNewswirePress Release

Entasis Therapeutics to Participate in Upcoming Healthcare Investor Conferences

WALTHAM, Mass., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX),... See more »
August 6, 2020GlobeNewswirePress Release

Entasis Therapeutics Reports Second Quarter 2020 Financial Results and Business Update

WALTHAM, Mass., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), ... See more »
August 5, 2020centralchartsPress Release

Entasis Therapeutics to Participate in Upcoming Healthcare Conferences

WALTHAM, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), ... See more »
July 13, 2020ZacksNews

Stock Rises 5.4%

Entasis Therapeutics (ETTX) saw a big move last session, as its shares jumped more than 5% on the day... See more »
July 6, 2020BioSpaceNews

Entasis Therapeutics Awarded Contract from National Institutes of Health

Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused... See more »
June 18, 2020BenzingaNews

Entasis Therapeutics to Participate in the BMO 2020 Prescriptions for Success Healthcare Conference

WALTHAM, Mass., June 18, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX), a... See more »
June 12, 2020BioSpaceNews

Entasis Therapeutics Completes Closing of Second Tranche of $35M Private Placement with Innoviva

Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) ("Entasis"), a clinical-stage biopharmaceutical com... See more »
May 7, 2020centralchartsPress Release

Entasis Therapeutics Reports First Quarter 2020 Financial Results and Business Update

WALTHAM, Mass., May 07, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a... See more »
October 30, 2019StreetInsiderPress Release

Entasis Therapeutics Appoints Dr. David Altarac as Chief Medical Officer

Dr. Robin Isaacs to Retire at the End of the Year WALTHAM, Mass., Oct. 30, 2019 (GLOBE NEWSWIRE) -- E... See more »
May 14, 2019GlobeNewswirePress Release

Entasis Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update

Transformative start to the year with the first Phase 3 trial underway and key additions to the leade... See more »
April 30, 2019GlobeNewswirePress Release

Entasis Therapeutics to Participate in the 5th Annual SunTrust Robinson Humphrey (STRH) Annual Life Sciences Summit

WALTHAM, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX),... See more »
April 4, 2019streetinsiderPress Release

Entasis Therapeutics Initiates Global Phase 3 Pivotal Trial of ETX2514SUL for Patients with Carbapenem-Resistant Acinetobacter Infections

WALTHAM, Mass., April 04, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX),... See more »
April 4, 2019CentralChartsPress Release

Entasis Therapeutics Initiates Global Phase 3 Pivotal Trial of ETX2514SUL for Patients with Carbapenem-Resistant Acinetobacter Infections

WALTHAM, Mass., April 04, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX),... See more »
Loading interface...
Loading interface...
Loading interface...
Loading interface...